Value of Oncology Innovation - Recognizing Benefits

The Value of Innovation in Oncology - Recognizing Emerging Benefits Over Time Executive Summary

An illustrated graphic of a piece of paper containing charts and text

To download the full report, click here.

A new white paper by Boston Healthcare Associates examines how innovative medicines are driving significant progress in the fight against cancer. Though initial approval by the U.S. Food and Drug Administration is a tremendous milestone, ongoing research and accumulation of knowledge reveals benefits that were not able to be recognized at that time. Through use in combinations, earlier in the disease progression, use with biomarkers, and even in other disease indications, additional value emerges over time.